Table 1.
Characteristics of participants included in the curated dataset and by reported COVID-19 test result.
| Total | All |
COVID+ |
COVID- |
|---|---|---|---|
| n = 12,117 | n = 865 | n = 1414 | |
| Demographics | |||
| Age in years, mean (SD) | 43 (14) | 40 (13) | 41 (13) |
| Age group | N (%) | N (%) | N (%) |
| 19–29 | 2382 (19.6) | 207 (23.9) | 285 (20.2) |
| 30–39 | 2634 (21.7) | 206 (23.8) | 324 (22.9) |
| 40–49 | 2613 (21.6) | 200 (23.1) | 341 (24.1) |
| 50–59 | 2219 (18.3) | 126 (14.6) | 248 (17.5) |
| 60+ | 1572 (13.0) | 70 (8.1) | 124 (8.8) |
| Did not respond | 697 (5.8) | 56 (6.5) | 92 (6.5) |
| Gender | |||
| Female | 8638 (71.3) | 591 (68.3) | 1001 (70.8) |
| Male | 3326 (27.4) | 268 (31.0) | 396 (28.0) |
| Self-reported as other | 153 (1.3) | 6 (0.7) | 17 (1.2) |
| Race | |||
| Black or African American | 924 (7.6) | 121 (14.0) | 120 (8.5) |
| White | 9208 (76.0) | 554 (64.0) | 1042 (73.7) |
| Other/Multiracial | 1957 (16.2) | 188 (21.7) | 251 (17.8) |
| Did not respond | 28 (0.2) | 2 (0.2) | 1 (0.1) |
| Ethnicity, Hispanic | 1439 (11.9) | 193 (22.3) | 183 (12.9) |
| Education | |||
| High school or less | 2333 (19.3) | 170 (19.7) | 230 (16.3) |
| Some college/2-year degree | 4284 (35.4) | 296 (34.2) | 445 (31.5) |
| 4-year college degree | 2802 (23.1) | 209 (24.2) | 338 (23.9) |
| >4-year college degree | 2658 (21.9) | 188 (21.7) | 396 (28.0) |
| Did not respond | 40 (0.3) | 2 (0.2) | 5 (0.4) |
| BMI categorya | |||
| Normal (<25) | 3859 (31.8) | 245 (28.3) | 463 (32.7) |
| Overweight (25–30) | 3037 (25.1) | 194 (22.4) | 354 (25.0) |
| Obese (≥30) | 4004 (33.0) | 320 (37.0) | 455 (32.2) |
| Comorbiditiesa | |||
| Pregnant | 85 (0.7) | 11 (1.3) | 10 (0.7) |
| Nicotine addiction (Smoker) | 2090 (17.2) | 98 (11.3) | 255 (18.0) |
| Lung disease | 1485 (12.3) | 114 (13.2) | 224 (15.8) |
| Organ transplant | 99 (0.8) | 22 (2.5) | 17 (1.2) |
| Cancer | 126 (1.0) | 25 (2.9) | 16 (1.1) |
| Cardiovascular disease | 735 (6.1) | 54 (6.2) | 107 (7.6) |
| Taking prescription medications for the following conditionsb | |||
| Hypertension | 2153 (17.8) | 151 (17.5) | 252 (17.8) |
| Diabetes | 973 (8.0) | 84 (9.7) | 128 (9.1) |
| Autoimmune disease | 897 (7.4) | 42 (4.9) | 135 (9.5) |
| Lung disease | 1128 (9.3) | 72 (8.3) | 184 (13.0) |
| Household exposure to COVID-19 or influenza-like illness | |||
| Yes | 2600 (21.5) | 371 (42.9) | 331 (23.4) |
Abbreviations: COVID+, participants who reported having had a positive COVID-19 test result; COVID-, participants who reported having had a negative COVID-19 test result; SD, standard deviation.
a
Approximately 10–12% of participants did not respond to one or more of these questions.
b
N = 852 (7%) of all participants, n = 80 (9.2%) of COVID+ and n = 97 (6.9%) of COVID-participants did not provide an answer in this section.